SIMULATIONS PLUS INC (SLP) Stock News

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024

Simulations Plus Q1 Earnings Assessment

Simulations Plus Reports First Quarter Fiscal 2025 Financial Results

Noteworthy Tuesday Option Activity: TTWO, SLP, WWD

Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date

Simulations Plus to Participate in the BTIG Digital Health Forum

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

Simulations Plus to Participate in the Stephens Annual Investment Conference

Simulations Plus is Now Oversold (SLP)

Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations

Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results

What to Expect from Simulations Plus's Earnings

Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date

Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings

Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions

Simulations Plus Releases DILIsym® X

Simulations Plus Releases ADMET Predictor® Version 12

Simulations Plus to Participate in KeyBanc’s 25th Annual Technology Leadership Forum

Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety

Simulations Plus Stock Drops 15% Despite EPS Beat

Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance.

SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q3 2024

SLP stock results show that Simulations Plus beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.

SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q3 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Simulations Plus (NASDAQ:SLP) just reported results for the third quarter of 20...

Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results

Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit

Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date